Technetium-99m HYNIC-annexin V: A potential radiopharmaceutical for the in-vivo detection of apoptosis

European Journal of Nuclear Medicine

Volumn 26, Issue 10, 1999, Pages 1251-1258

  Ohtsuki, Katsuichi ^a   Akashi, Koichi ^a   Aoka, Yoshikazu ^b   Blankenberg, Francis G ^a   Kopiwoda, Susan ^a   Tait, Jonathan F ^c   Strauss, H William ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Annexin V; Apoptosis; Technetium 99m

Indexed keywords

DEXAMETHASONE; FAS ANTIGEN; FAS LIGAND; HOE 33342; LIPOCORTIN 5; NICOTINAMIDE DERIVATIVE; PHOSPHATIDYLSERINE; PROPIDIUM IODIDE; RADIOPHARMACEUTICAL AGENT; REAGENT; TECHNETIUM 99M;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COMMUNICATION; CELL FUNCTION; CELL MEMBRANE; DRUG DISTRIBUTION; FLUORESCENCE ACTIVATED CELL SORTER; HISTOLOGY; ISOTOPE LABELING; LIVER; MEDICAL DECISION MAKING; MOUSE; NONHUMAN; RADIOACTIVITY; SCINTILLATION COUNTING; THYMUS;

ANIMALS; ANNEXIN A5; ANTI-INFLAMMATORY AGENTS; ANTIGENS, CD95; APOPTOSIS; COLORING AGENTS; CONTRAST MEDIA; DEXAMETHASONE; FLOW CYTOMETRY; HUMANS; IN SITU NICK-END LABELING; INJECTIONS, INTRAVENOUS; LIVER; MICE; MICE, INBRED BALB C; MICE, INBRED MRL LPR; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; RATS; THYMUS GLAND; TISSUE DISTRIBUTION;

EID: 0003074186     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050580     Document Type: Article

References (33)

1. Kerr JF, Wynnllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-257.
2. Sneller MC, Wang J, Dale JK, Strober W, Middelton LA, Choi Y, Fleisher TA, Lim MS, Jaffe ES, Puck JM, Lenardo MJ, Straus SE. Clincial, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood 1997; 15: 1341-1348.
3. Sambhara SR, Miller RG. Programmed cell death of T cells signaled by the T cell receptor and the alpha 3 domain of class I MHC. Science 1991; 252: 1424-1427.
4. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267: 1456-1462.
5. Steller H. Mechanisms and genes of cellular suicide. Science 1995; 267: 1445-1449.
6. Narula J, Haider N, Virmani R, et al. Apoptosis in myocytes in end-stage heart failure [see comments]. N Engl J Med 1996; 335: 1182-1189.
7. Martin SJ, Reutelingsperger CP, McGahon AJ, et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 1995; 182: 1545-1556.
8. Verhoven B, Schlegel RA, Williamson P. Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J Exp Med 1995; 182: 1597-1601.
9. Zachowski A, Favre E, Cribier S, Herve P, Devaux PF. Outside-inside translocation of aminophospholipids in the human erythrocyte membrane is mediated by a specific enzyme [published erratum appears in Biochemistry 1986; 25: 7788]. Biochemistry 1986; 25: 2585-2590.
10. Sune A, Bette-Bobillo P, Bienvenue A, Fellmann P, Devaux PF. Selective outside-inside translocation of aminophospholipids in human platelets. Biochemistry 1987; 26: 2972-2978.
11. Wyllie AH, Kerr JF, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980; 68: 251-306.
12. Tait JF, Gibson D, Fujikawa K. Phospholipid binding properties of human placental anticoagulant protein-I, a member of the lipocortin family. J Biol Chem 1989; 264: 7944-7949.
13. Andree HA, Reutelingsperger CP, Hauptmann R, Hemker HC, Hermens WT, Willems GM. Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. J Biol Chem 1990; 265: 4923-4928.
14. Raynal P, Pollard HB. Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins. Biochim Biophys Acta 1994; 1197: 63-93.
15. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994; 84: 1415-1420.
16. van Heerde WL, de Groot PG, Reutelingsperger CP. The complexity of the phospholipid binding protein Annexin V. Thromb Haemost 1995; 73: 172-179.
17. Tait JF, Gibson D. Measurement of membrane phospholipid asymmetry in normal and sickle- cell erythrocytes by means of annexin V binding. J Lab Clin Med 1994; 123: 741-748.
18. Wood BL, Gibson DF, Tait JF. Increased erythrocyte phosphatidylserine exposure in sickle cell disease: flow-cytometric measurement and clinical associations. Blood 1996; 88: 1873-1880.
19. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. J Immunol Methods 1995; 184: 39-51.
20. Blankenberg FG, Katsikis PD, Tait JF, Davis RE, Naumovski L, Ohtsuki K, Kopiwoda S, Abrams MJ, Darkes M, Robbins RC, Maecker HT, Strauss HW. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci USA 1998; 95: 6349-6354.
21. 99mTc annexin V. J Nucl Med 1999; 40: 184-191.
22. Vriens PW, Blankenberg FG, Stoot JH, Ohtsuki K, Berry GJ, Tait JF, Strauss HW, Robbins RC. The use of technetium Tc 99m annex in V for in vivo imaging of apoptosis during cardiac allograft rejection. J Thorac Cardiovasc Surg 1998 116: 844-853.
23. Tait JF, Engelhardt S, Smith C, Fujikawa K. Pro-urokinase-annexin V chimeras. Construction, expression, and characterization of recombinant proteins. J Biol Chem 1995; 270: 21594-21599.
24. Tait JF, Smith C. Site-specific mutagenesis of annexin V: role of residues from Arg-200 to Lys-207 in phospholipid binding. Arch Biochem Biophys 1991; 288: 141-144.
25. Abrams MJ, Juweid M, tenKate CI, Schwartz DA, Hauser MM, Gaul FE, Fuccello AJ, Rubin RH, Strauss HW, Fischman AJ. Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. J Nucl Med 1990; 31: 2022-2028.
26. Sun XM, Snowden RT, Skilleter DN, Dinsdale D, Ormerod MG, Cohen GM. A flow-cytometric method for the separation and quantitation of normal and apoptotic thymocytes. Anal Biochem 1992; 204: 351-356.
27. Cohen GM, Sun XM, Snowden RT, Ormerod MG, Dinsdale D. Identification of a transitional preapoptotic population of thymocytes [published erratum appears in J Immunol 1993; 151: 6616]. J Immunol 1993; 151: 566-574.
28. Sha WC, Nelson CA, Newberry RD, Kranz DM, Russell JH, Loh DY. Positive and negative selection of an antigen receptor on T cells in transgenic mice. Nature 1988; 336: 73-76.
29. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992; 119: 493-501.
30. Ogasawara J, Watanabe-Fukunaga R, Adachi M, et al. Lethal effect of the anti-Fas antibody in mice [published erratum appears in Nature 1993 365: 568]. Nature 1993; 364: 806-809.
31. Tait JF, Cerqueira MD, Dewhurst TA, Fujikawa K, Ritchie JL, Stratton JR. Evaluation of annexin V as a platelet-directed thrombus targeting agent. Thromb Res 1994 75: 491-501.
32. Sterin-Speziale N, Kahane VL, Setton CP, Fernandez MC, Speziale EH. Compartmental study of rat renal phospholipid metabolism. Lipids 1992; 27: 10-14.
33. Zaitseva MB, Mojcik CF, Salomon DR, Shevach EM, Golding H Co-ligation of alpha4betal integrin and TCR rescues human thymocytes from steroid-induced apoptosis. Int Immunol 1998; 10: 1551-1561.